Medindia

X

Kiwa Bio-Tech in Collaboration Discussions with Beijing Hai Xin Science and Technology Co., Ltd.

Tuesday, May 20, 2008 General News J E 4
Advertisement
BEIJING and CLAREMONT, Calif.*, May 19 Kiwa Bio-Tech Products Group Corporation (OTC Bulletin Board: KWBT) announceddiscussions with Beijing Hai Xin Science and Technology Co., Ltd. ("Hai Xin")regarding joint product development and marketing efforts. This May, the BoardChairman of Hai Xin, Mr. Haiming Sun, and Mr. Ming Yang, the CFO, visitedKiwa's Beijing headquarters.

Hai Xin is a high technology enterprise that specializes in mineralresource development of nonmetallic clays and earths in order to enhance thenatural functions of the materials. By combining these earths with organicmaterials, improved bio-feeds and bio-fertilizers can be manufactured forfarming operations.

Hai Xin has mineral resource exploitation rights for land that containsover 50,000,000 metric tons of palygorskite. The Company also holds severaltechnology patents for processing palygorskite into feed additive products andagricultural fertilizer products.

Mr. Sun stated, "Hai Xin has determined that Kiwa's bio-fertilizerproducts and bio-feed products are gaining recognition and market share inChina. Meanwhile, by dint of the development strength of China AgriculturalUniversity, Kiwa-CAU R&D Centre is a product development leader of China'sagricultural technological industry."

Mr. Sun continued, "Hai Xin is examining the feasibility of assigning useof it's patents and technology related to mineral resources to Kiwa with theobjective of working together to develop new products to improve farming inChina. Hai Xin hopes cooperation with Kiwa to combine our palygorskiteproducts with Kiwa's existing products and the efforts of Kiwa-CAU R&D Centrewill allow further development of advanced agricultural products. We hope towork together marketing these products and expanding the marketing position ofboth companies."

ABOUT KIWA BIO-TECH PRODUCTS GROUP CORPORATION

The Company develops, manufactures, distributes and markets innovative,cost-effective, and environmentally safe bio-technological products foragricultural and natural resources and environmental conservation. TheCompany's products are designed to enhance the quality of human life byincreasing the value, quality and productivity of crops and decreasing thenegative environmental impact of chemicals and other wastes. For moreinformation about the Company, please review documents filed with the SEC(www.sec.gov) or visit the Company's website at http://www.kiwabiotech.com .

* Effective today, Kiwa's California office has moved to: 310 N. Indian

Hill Blvd., #702, Claremont, CA 91711

This press release contains information that constitutes forward-lookingstatements made pursuant to the safe harbor provisions of the PrivateSecurities Litigation Reform Act of 1995. Any such forward-looking statementsinvolve risk and uncertainties that could cause actual results to differmaterially from any future results described by the forward-looking statements.Risk factors that could contribute to such differences include those mattersmore fully disclosed in the Company's reports filed with the Securities andExchange Commission. The forward-looking information provided hereinrepresents the Company's estimates as of the date of the press release, andsubsequent events and developments may cause the Company's estimates to change.The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking informationshould not be relied upon as representing the Company's estimates of itsfuture financial performance as of any date subsequent to the date of thispress release.For more information, please contact: Kiwa Bio-Tech Products Group Corporation Yvonne Wang 310 N. Indian Hill Blvd., #702 Claremont CA 91711 Tel: +1-626-715-5855 Email: kiwabiotech@gmail.com Robert Schechter Equity Communicatio
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
National Business Group on Health Honors Erie Insu...
S
The Epilepsy Foundation Sheds Light on Seizures